Amylyx Pharmaceuticals, Inc.AMLXNASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank83
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Percentile
P83
Within normal range
vs 2Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
202526.43%
2024-1506.55%
2023106.63%
2022-140.47%
2021-103.83%
2020-243.38%
20190.00%